Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Shafina Jahan's research investigates viral pathogens and their impact on human health, with a particular focus on developing diagnostic and therapeutic strategies. Her work includes studying the potential antiviral activity of S-adenosyl-L-homocysteine against Dengue Virus Serotype-3 (DENV-3) and developing standardized pseudotyped virus-based neutralization assays for candidate Nipah virus vaccines. Jahan has also explored the virome profiles of placentas in term and preterm pregnancies across diverse populations, contributing to a broader understanding of microbial communities in maternal and perinatal health. Additionally, her research has examined specific viral lineages, such as a SARS-CoV-2 B.1.1.25 lineage identified in a neonate. Jahan collaborates with researchers at the University of Arkansas for Medical Sciences, including Dipok Kumer Shill and Mohammad Mamun Alam.
Metrics
- h-index: 1
- Publications: 5
- Citations: 7
Selected Publications
-
Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function (2026)
-
Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines (2025)
Collaboration Network
Top Collaborators
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function
- Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function
- Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function
- Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function
- Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function
Similar Researchers
Based on overlapping research topics